Dr. Qingping Feng named Innovator of the Year for potential sepsis treatment
WORLDiscoveries, the technology transfer and business development office for Western University, Lawson Health Research Institute and Robarts Research Institute, recently announced the recipients of the 2020 Vanguard Awards.
Vanguard Awards recognize local researchers who, through partnership with WORLDiscoveries, have achieved various market-readiness milestones.
Lawson’s Dr. Qingping Feng was named as the Innovator of the Year. He is being recognized for his research and intellectual property related to Annexin and its use to treat inflammatory disorders. He holds patents issued in Canada, United States, Europe, China and Japan.
This award is given to individuals who demonstrate excellence in innovation within their field. It highlights the achievements of those who contribute to the culture of commercialization and entrepreneurship by creating a product or service that is beneficial to society.
Congratulations to Dr. Feng and all of the 2020 Vanguard Award recipients.
As the research institute of LHSC and St. Joseph’s, our researchers work in the lab and directly with clinicians, patients, families and other partners to enhance diagnostics and treatments. They also address care at a system level by improving delivery of services for people in London and beyond.
For any pressing health question, our work does not stop once the research is done. Commercialization and business development are vital components in driving innovation and transforming health care, all while supporting Canada’s knowledge economy.
Learn more about Dr. Feng’s research:
Scientist
